Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...

Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...

HRT patches for menopause ‘can help treat prostate cancer’ – but there is one main side effect - Patches that lower ...

Camcevi ETM contains 21mg of leuprolide and is administered every 3 months. The Food and Drug Administration (FDA) has approved Camcevi ETM ®, a long-acting formulation of leuprolide mesylate, for the ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding ...

Advanced prostate cancer treatment requires a personalized approach, considering disease stage, comorbidities, and patient preferences. ARPIs have revolutionized treatment, highlighting the need for ...

*Localized: T 1/2, NX or N0, and M0. ‡ Locally advanced: T3/4, NX or N0, and M0, or N1 and M0. ITT: Intention to treat; PSA: Prostate-specific antigen. Reproduced ...

Hormone replacement therapy patches used for menopausal women can also treat prostate cancer in men, a study has found.

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 prostate cancer-related deaths. As such, prostate cancer remains the most ...

St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programme Dr Kenrick Ng, Medical Oncology Consultant, St Bartholomew's Hospital, ...